2024 Global Hepatitis Report
WHO sounds alarm on viral hepatitis infections claiming 3500 lives each day. Viral hepatitis is the second leading infectious cause of death globally. More
Calendar
Recent materials
Drug Policy Manifesto for the 2024 European Parliament Elections
For a drug policy that makes Europe safer, healthier, and more just! A Manifesto, initiated by C-EHRN, lays down a vision for a pragmatic, innovative, and human rights-centred European drug policy. More
EuroNPUD Technical Briefing: Community-Led Approaches to HCV Testing, Treatment and Care
A Technical Briefing spotlights successful community-led approaches in Portugal and Norway, offering valuable insights into the effectiveness of integrating peer-led initiatives into HCV healthcare strategies. More
Medicines for HIV, Viral Hepatitis, and STIs in LMICs: Forecasts of Global Demand for 2022-2026
WHO releases a report jointly presenting medicines forecasts across three disease areas in recognition of the benefits of addressing HIV, viral hepatitis and STIs in a coordinated manner. More
Consolidated Guidelines on Person-Centred Viral Hepatitis Strategic Information
WHO releases a publication summarizing the proposed approach to collect, analyse, report, disseminate and use strategic information on viral hepatitis at the subnational, national and global levels. More
Progress Towards Elimination of Viral Hepatitis: a Lancet Gastroenterology & Hepatology Commission Update
The Commission update focuses on national progress among the 20 countries most heavily burdened with viral hepatitis (75% of the global burden). An effective response in these countries is crucial if global elimination targets are to be achieved. More
